{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:00:48Z","timestamp":1794488448609,"version":"4.9.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019533","name":"Moderna","doi-asserted-by":"publisher","award":["CIN-13-419"],"award-info":[{"award-number":["CIN-13-419"]}],"id":[{"id":"10.13039\/100019533","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.vaccine.2026.128882","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T23:54:08Z","timestamp":1783641248000},"page":"128882","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025\u20132026"],"prefix":"10.1016","volume":"88","author":[{"given":"Kevin W.","family":"McConeghy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elissa H.","family":"Wilker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"DeVone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Patry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Claire","family":"Newbern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre B.","family":"Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parinaz","family":"Ghaswalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer R.","family":"Tufts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasin","family":"Abul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gravenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2026.128882_bb0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.44756","article-title":"Burden of Respiratory Syncytial Virus\u2013Associated Hospitalizations in US Adults, October 2016 to September 2023","volume":"7","author":"Havers","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128882_bb0010","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/S0140-6736(24)01738-0","article-title":"Respiratory syncytial virus (RSV) vaccine effectiveness against RSV-associated hospitalisations and emergency department encounters among adults aged 60 years and older in the USA, October, 2023, to March, 2024: a test-negative design analysis","volume":"404","author":"Payne","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2026.128882_bb0015","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1001\/jamainternmed.2025.6355","article-title":"Durability of respiratory syncytial virus vaccine effectiveness among US veterans","volume":"186","author":"Bajema","year":"2026","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.vaccine.2026.128882_bb0020","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa2307079","article-title":"Efficacy and safety of an mRNA-based RSV PreF vaccine in older adults","volume":"389","author":"Wilson","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128882_bb0025","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1056\/NEJMoa2213836","article-title":"Efficacy and safety of a bivalent RSV Prefusion F vaccine in older adults","volume":"388","author":"Walsh","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128882_bb0030","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1056\/NEJMoa2209604","article-title":"Respiratory syncytial virus Prefusion F protein vaccine in older adults","volume":"388","author":"Papi","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128882_bb0040","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8322","article-title":"Effectiveness and safety of respiratory syncytial virus vaccine for US adults aged 60 years or older","volume":"8","author":"Fry","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128882_bb0045","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.50832","article-title":"Estimated Vaccine Effectiveness for Respiratory Syncytial Virus\u2013Related Lower Respiratory Tract Disease","volume":"7","author":"Tartof","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.vaccine.2026.128882_bb0055","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1093\/gerona\/glab071","article-title":"Updating and validating the U.S. veterans affairs frailty index: transitioning from ICD-9 to ICD-10","volume":"76","author":"Cheng","year":"2021","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.vaccine.2026.128882_bb0065","article-title":"Analysis of matched case-control studies","volume":"352","author":"Pearce","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.vaccine.2026.128882_bb0070","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMsa2514268","article-title":"Updated evidence for Covid-19, RSV, and influenza vaccines for 2025\u20132026","volume":"393","author":"Scott","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2026.128882_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MLR.0000000000002159","article-title":"Chronic condition burden by veteran status, veterans health administration enrollment, and age using nationally representative survey data","volume":"63","author":"Chawla","year":"2025","journal-title":"Med Care"},{"key":"10.1016\/j.vaccine.2026.128882_bb0080","article-title":"Exploring health outcomes for U.S. veterans compared to non-veterans from 2003 to 2019","volume":"9","author":"Betancourt","year":"2021","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.vaccine.2026.128882_bb0090","doi-asserted-by":"crossref","first-page":"ofae097","DOI":"10.1093\/ofid\/ofae097","article-title":"Attributable cost of adult respiratory syncytial virus illness beyond the acute phase","volume":"11","author":"Averin","year":"2024","journal-title":"Open forum Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.vaccine.2026.129072","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000}},{"DOI":"10.1016\/j.vaccine.2026.129072","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000}}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26006912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:40:24Z","timestamp":1789504824000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26006912"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":14,"alternative-id":["S0264410X26006912"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128882","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine effectiveness of mRNA-1345 against RSV-associated hospitalization and medically attended acute respiratory illness among US veterans, 2025\u20132026","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128882","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128882"}}